January 15, 2025 · Form 4 insider transaction
Schneider Eugene bought 33,000 shares of Ionis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.; Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.; Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.